Figure 3.
Most common adverse events presented by treatment cycles. The incidence of different grades of adverse events was assessed in each neoadjuvant therapy cycle. WBC, white blood cell.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.